Corrigendum to “Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance” [Gynecol. Oncol. Rep. 34 (2020) 100648]

Spremljeno u:
Bibliografski detalji
Izdano u:Gynecol Oncol Rep
Glavni autori: Oh, Jonathan, Barve, Minal, Senzer, Neil, Aaron, Phylicia, Manning, Luisa, Wallraven, Gladice, Bognar, Ernest, Stanbery, Laura, Horvath, Staci, Manley, Meghan, Nemunaitis, John, Walter, Adam, Rocconi, Rodney P.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2021
Teme:
Corrigendum
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8169695/
https://ncbi.nlm.nih.gov/pubmed/34095420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gore.2021.100740
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items